SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.980
+0.190 (10.61%)
At close: May 12, 2025, 4:00 PM
2.036
+0.056 (2.83%)
After-hours: May 12, 2025, 7:52 PM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $18.39 million as of May 12, 2025. Its market cap has decreased by -54.69% in one year.
Market Cap
18.39M
Enterprise Value
10.98M
1-Year Change
-54.69%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $18.39M, a decrease of -85.93%. That is a compound annual growth rate of -36.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 16.63M | -52.52% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |